No Picture
Trading Ideas

Were Hedge Funds Right About AbbVie Inc (ABBV)?

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […] …read more […]

No Picture
Trading Ideas

Understanding the Life – and Death – of Great Stocks

Alexander Green knows what it takes to beat the market… and it’s not a subscription to the psychic network.
Today, he’s sharing the two things every investor needs to earn market-beating returns.

I’ve written often about how the best investors beat the market.
It’s not by guessing whether to be in the market or out. It’s by owning individual stocks that give higher returns than the broad market.
Ask an auditorium full of investors “Who’s the greatest stock picker of all time?” and you’ll get a variety of good answers (starting with Warren Buffett).
But ask that same auditorium “Who’s the greatest market timer of …read more […]

No Picture
Trading Ideas

Sycamore Seeks to Scrap Victoria’s Secret Deal; L Brands Plunges

(Bloomberg) — Sycamore Partners moved to terminate its purchase of a controlling stake in lingerie brand Victoria’s Secret from L Brands Inc., saying the retailer can’t blame the coronavirus outbreak for violating terms of the agreement.The private equity firm said moves such as failing to pay rent and furloughing thousands of workers amid widespread retail disruption sparked by the outbreak have reduced the company’s value. “That these actions were taken as a result of or in response to the Covid-19 pandemic is no defense,” according to the complaint in the Delaware Chancery Court.If the deal is canceled, it will be …read more […]

No Picture
Trading Ideas

What is the Best Way to Invest in Gold in 2020?

Are you looking for the best ways to invest in gold in 2020? Overall, there are a variety of options for investors. You can expand your portfolio today without ever holding a gold bar in your hands.
Gold is a staple for many investors due to a wide range of reasons. It’s a great safety net for inflation. Furthermore, it can become a useful hedging strategy in a volatile market.
This precious metal has been valuable for all of recent history. It can hold its value or rise in price no matter the economic climate. In today’s market, gold provides a great …read more […]

No Picture
Trading Ideas

Sycamore Partners seeks to end Victoria's Secret deal, L Brands shares plunge

Sycamore said less than one month after entering the deal with L Brands, the company closed nearly all of its about 1,600 Victoria’s Secret and PINK stores globally, including more than a thousand stores in North America. L Brands also furloughed most of its Victoria’s Secret employees and reduced compensation for senior staff and took other actions that could hurt the lingerie business, Sycamore said in the filing. …read more […]

No Picture
Trading Ideas

‘It’s been very impressive….the speed and the size of the fiscal response’: Analyst weighs in on PPP funding

The small-business loans program officially tapped out of funding last week. The Senate passed the $484 billion for small-businesses to receive stimulus relief. John Tobin, Epoch Investment Partners Managing Director and Portfolio Manager & Senior Research Analyst joins Yahoo Finance’s On The Move to discuss. …read more […]

No Picture
Trading Ideas

Pfizer Rises on Nod to Start First In-Human COVID-19 Vaccine Trial in Germany

U.S. drugmaker Pfizer Inc. (PFE) and BioNTech SE (BNTX) got the green light from German regulators to conduct the first in-human clinical trial in Germany of a potential coronavirus vaccine.Pfizer and BioNTech said they expected shortly to get regulatory approval to also start clinical trials in the U.S. Pfizer shares rose as much as 10% in early morning trading and were priced at $36.38 around midday. BioNtech stock surged 14% to $48.35.The Phase 1/2 trial comprises 4 vaccine candidates. The trial will include about 200 healthy individuals between the ages of 18 to 55 and aims to test the safety …read more […]